IFL chemotherapy
WikiDoc Resources for IFL chemotherapy |
Articles |
---|
Most recent articles on IFL chemotherapy Most cited articles on IFL chemotherapy |
Media |
Powerpoint slides on IFL chemotherapy |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on IFL chemotherapy at Clinical Trials.gov Trial results on IFL chemotherapy Clinical Trials on IFL chemotherapy at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on IFL chemotherapy NICE Guidance on IFL chemotherapy
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on IFL chemotherapy Discussion groups on IFL chemotherapy Patient Handouts on IFL chemotherapy Directions to Hospitals Treating IFL chemotherapy Risk calculators and risk factors for IFL chemotherapy
|
Healthcare Provider Resources |
Causes & Risk Factors for IFL chemotherapy |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
IFL is a chemotherapy regimen for treatment of certain cancers, consisting of concurrent treatment with irinotecan, leucovorin (folinic acid), and fluorouracil.
It is similar to the FOLFIRI regimen and uses the same drugs. However, the flurouracil component is given as a bolus injection rather than as an infusion over 48 hours.